Rates of Cardiac Stress Testing Down but Still Higher in CKD

Share this content:

(HealthDay News) -- From 2008 to 2012 there was a decrease in overall rates of cardiac stress testing in Medicare beneficiaries, though rates were consistently higher for patients with chronic kidney disease (CKD) than those without CKD, according to a study published online June 13 in JACC: Cardiovascular Imaging.

Charles A. Herzog, M.D., from the University of Minnesota in Minneapolis, and colleagues identified Medicare beneficiaries aged 66 years or older undergoing a first cardiac stress test from 2008 to 2012. Testing rates were compared for patients with CKD and those without CKD.

About 480,000 patients underwent stress tests in 2008 (about 29,000 with CKD) compared with about 400,000 patients in 2012 (about 38,000 with CKD). The researchers found that in 2008 and 2012, 78 to 80 percent and 87 to 88 percent of all stress testing in non-CKD and CKD patients, respectively, used nuclear imaging. From 2008 to 2012 there was a decrease in the rate of stress testing, from 11.5 to 9.4 per 100 patient years for non-CKD patients and from 16.8 to 13.4 per 100 patient-years for CKD patients. With non-CKD as the reference, the likelihood of stress testing increased with worsening CKD.

"Overall rates of cardiac stress testing (over three-fourths using nuclear imaging) declined 2008 to 2012 in Medicare beneficiaries aged 66 years or older, but were consistently higher for CKD than for non-CKD patients," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Cap'n Crunch Cereal Recalled Due to Salmonella Scare

Cap'n Crunch Cereal Recalled Due to <i>Salmonella</i> Scare

No illnesses related to the products have been reported to date

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

Adcetris approved in combination with chemo to treat systemic anaplastic large cell lymphoma

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

Four infants in Texas hospitalized with botulism after using pacifiers containing honey

is free, fast, and customized just for you!




Already a member?

Sign In Now »